APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccination

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchOral Vaccination Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccination Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Oral Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccination Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccination Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral Vaccination market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Vaccination include Lanzhou Institute, Tiantan Biological, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Vaccination market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Vaccination and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Vaccination sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Vaccination market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Vaccination Segment by Company

Lanzhou Institute

Tiantan Biological

Sanofi

Merck

Shanghai United Cell

GSK

Valneva

Vabiotech

Serum Institute

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

Emergent BioSolutions

Bio-Med

Bibcol

Oral Vaccination Segment by Type

Rotavirus Vaccine

Oral Polio Vaccine

Cholera Vaccine

Other

Oral Vaccination Segment by Application

Public

Private

Oral Vaccination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccination market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Vaccination Industry Trends Table 2. Oral Vaccination Industry Drivers Table 3. Oral Vaccination Industry Opportunities and Challenges Table 4. Oral Vaccination Industry Restraints Table 5. Global Oral Vaccination Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Vaccination Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Vaccination Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oral Vaccination Sales Market Share by Manufacturers Table 9. Global Oral Vaccination Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oral Vaccination Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Vaccination Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Vaccination Manufacturers, Product Type & Application Table 13. Global Oral Vaccination Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Vaccination by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rotavirus Vaccine Table 17. Major Manufacturers of Oral Polio Vaccine Table 18. Major Manufacturers of Cholera Vaccine Table 19. Major Manufacturers of Other Table 20. Global Oral Vaccination Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Oral Vaccination Sales by Type (2021-2026) & (k units) Table 22. Global Oral Vaccination Sales by Type (2027-2032) & (k units) Table 23. Global Oral Vaccination Sales Market Share by Type (2021-2026) Table 24. Global Oral Vaccination Sales Market Share by Type (2027-2032) Table 25. Global Oral Vaccination Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Oral Vaccination Revenue by Type (2021-2026) & (k units) Table 27. Global Oral Vaccination Revenue by Type (2027-2032) & (k units) Table 28. Global Oral Vaccination Revenue Market Share by Type (2021-2026) Table 29. Global Oral Vaccination Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Public Table 31. Major Manufacturers of Private Table 32. Global Oral Vaccination Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Oral Vaccination Sales by Application (2021-2026) & (k units) Table 34. Global Oral Vaccination Sales by Application (2027-2032) & (k units) Table 35. Global Oral Vaccination Sales Market Share by Application (2021-2026) Table 36. Global Oral Vaccination Sales Market Share by Application (2027-2032) Table 37. Global Oral Vaccination Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Oral Vaccination Revenue by Application (2021-2026) & (k units) Table 39. Global Oral Vaccination Revenue by Application (2027-2032) & (k units) Table 40. Global Oral Vaccination Revenue Market Share by Application (2021-2026) Table 41. Global Oral Vaccination Revenue Market Share by Application (2027-2032) Table 42. Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Oral Vaccination Sales by Region (2021-2026) & (k units) Table 44. Global Oral Vaccination Sales Market Share by Region (2021-2026) Table 45. Global Oral Vaccination Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Oral Vaccination Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Oral Vaccination Sales by Country (2021-2026) & (k units) Table 49. North America Oral Vaccination Sales by Country (2027-2032) & (k units) Table 50. Europe Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Oral Vaccination Sales by Country (2021-2026) & (k units) Table 52. Europe Oral Vaccination Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Oral Vaccination Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Oral Vaccination Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Oral Vaccination Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Oral Vaccination Sales by Country (2027-2032) & (k units) Table 59. Global Oral Vaccination Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Oral Vaccination Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Oral Vaccination Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Oral Vaccination Revenue Market Share by Region (2021-2026) Table 63. Global Oral Vaccination Revenue Market Share by Region (2027-2032) Table 64. Lanzhou Institute Company Information Table 65. Lanzhou Institute Business Overview Table 66. Lanzhou Institute Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Lanzhou Institute Oral Vaccination Product Portfolio Table 68. Lanzhou Institute Recent Development Table 69. Tiantan Biological Company Information Table 70. Tiantan Biological Business Overview Table 71. Tiantan Biological Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Tiantan Biological Oral Vaccination Product Portfolio Table 73. Tiantan Biological Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sanofi Oral Vaccination Product Portfolio Table 78. Sanofi Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Merck Oral Vaccination Product Portfolio Table 83. Merck Recent Development Table 84. Shanghai United Cell Company Information Table 85. Shanghai United Cell Business Overview Table 86. Shanghai United Cell Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shanghai United Cell Oral Vaccination Product Portfolio Table 88. Shanghai United Cell Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GSK Oral Vaccination Product Portfolio Table 93. GSK Recent Development Table 94. Valneva Company Information Table 95. Valneva Business Overview Table 96. Valneva Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Valneva Oral Vaccination Product Portfolio Table 98. Valneva Recent Development Table 99. Vabiotech Company Information Table 100. Vabiotech Business Overview Table 101. Vabiotech Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Vabiotech Oral Vaccination Product Portfolio Table 103. Vabiotech Recent Development Table 104. Serum Institute Company Information Table 105. Serum Institute Business Overview Table 106. Serum Institute Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Serum Institute Oral Vaccination Product Portfolio Table 108. Serum Institute Recent Development Table 109. Panacea Biotec Ltd Company Information Table 110. Panacea Biotec Ltd Business Overview Table 111. Panacea Biotec Ltd Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Panacea Biotec Ltd Oral Vaccination Product Portfolio Table 113. Panacea Biotec Ltd Recent Development Table 114. Halfkin Bio-Pharmaceuticals Company Information Table 115. Halfkin Bio-Pharmaceuticals Business Overview Table 116. Halfkin Bio-Pharmaceuticals Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio Table 118. Halfkin Bio-Pharmaceuticals Recent Development Table 119. EuBiologics Company Information Table 120. EuBiologics Business Overview Table 121. EuBiologics Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. EuBiologics Oral Vaccination Product Portfolio Table 123. EuBiologics Recent Development Table 124. Emergent BioSolutions Company Information Table 125. Emergent BioSolutions Business Overview Table 126. Emergent BioSolutions Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Emergent BioSolutions Oral Vaccination Product Portfolio Table 128. Emergent BioSolutions Recent Development Table 129. Bio-Med Company Information Table 130. Bio-Med Business Overview Table 131. Bio-Med Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Bio-Med Oral Vaccination Product Portfolio Table 133. Bio-Med Recent Development Table 134. Bibcol Company Information Table 135. Bibcol Business Overview Table 136. Bibcol Oral Vaccination Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Bibcol Oral Vaccination Product Portfolio Table 138. Bibcol Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Oral Vaccination Distributors List Table 142. Oral Vaccination Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Oral Vaccination Product Image Figure 2. Global Oral Vaccination Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccination Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Vaccination Sales (2021-2032) & (k units) Figure 5. Global Oral Vaccination Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Vaccination Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rotavirus Vaccine Image Figure 9. Oral Polio Vaccine Image Figure 10. Cholera Vaccine Image Figure 11. Other Image Figure 12. Global Oral Vaccination Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Oral Vaccination Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Oral Vaccination Sales Market Share by Type (2021-2032) Figure 15. Global Oral Vaccination Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Oral Vaccination Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Oral Vaccination Revenue Market Share by Type (2021-2032) Figure 18. Public Image Figure 19. Private Image Figure 20. Global Oral Vaccination Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Oral Vaccination Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Oral Vaccination Sales Market Share by Application (2021-2032) Figure 23. Global Oral Vaccination Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Oral Vaccination Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Oral Vaccination Revenue Market Share by Application (2021-2032) Figure 26. North America Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Oral Vaccination Sales Market Share by Country (2021-2032) Figure 28. U.S. Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Oral Vaccination Sales Market Share by Country (2021-2032) Figure 33. Germany Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Oral Vaccination Sales Market Share by Country (2021-2032) Figure 40. China Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Oral Vaccination Sales Market Share by Country (2021-2032) Figure 48. Brazil Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Oral Vaccination Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Oral Vaccination Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Oral Vaccination Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Oral Vaccination Revenue (2021-2032) & (US$ Million) Figure 59. North America Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Oral Vaccination Revenue (2021-2032) & (US$ Million) Figure 61. Europe Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Oral Vaccination Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Oral Vaccination Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Oral Vaccination Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral Vaccination Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Oral Polio Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Public
  • Private
Companies covered
  • Lanzhou Institute
  • Tiantan Biological
  • Sanofi
  • Merck
  • Shanghai United Cell
  • GSK
  • Valneva
  • Vabiotech
  • Serum Institute
  • Panacea Biotec Ltd
  • Halfkin Bio-Pharmaceuticals
  • EuBiologics
  • Emergent BioSolutions
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Vaccination Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Vaccination Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Vaccination Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Vaccination Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Vaccination Market Dynamics
  1. 2.1 Oral Vaccination Industry Trends
  2. 2.2 Oral Vaccination Industry Drivers
  3. 2.3 Oral Vaccination Industry Opportunities and Challenges
  4. 2.4 Oral Vaccination Industry Restraints
3 Oral Vaccination Market by Manufacturers
  1. 3.1 Global Oral Vaccination Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Vaccination Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Vaccination Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Vaccination Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Vaccination Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Vaccination Manufacturers, Product Type & Application
  7. 3.7 Global Oral Vaccination Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Vaccination Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Vaccination Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Vaccination Tier 1, Tier 2, and Tier 3
4 Oral Vaccination Market by Type
  1. 4.1 Oral Vaccination Type Introduction
  2. 4.1.1 Rotavirus Vaccine
  3. 4.1.2 Oral Polio Vaccine
  4. 4.1.3 Cholera Vaccine
  5. 4.1.4 Other
  6. 4.2 Global Oral Vaccination Sales by Type
  7. 4.2.1 Global Oral Vaccination Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oral Vaccination Sales by Type (2021-2032)
  9. 4.2.3 Global Oral Vaccination Sales Market Share by Type (2021-2032)
  10. 4.3 Global Oral Vaccination Revenue by Type
  11. 4.3.1 Global Oral Vaccination Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oral Vaccination Revenue by Type (2021-2032)
  13. 4.3.3 Global Oral Vaccination Revenue Market Share by Type (2021-2032)
5 Oral Vaccination Market by Application
  1. 5.1 Oral Vaccination Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Vaccination Sales by Application
  5. 5.2.1 Global Oral Vaccination Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Vaccination Sales by Application (2021-2032)
  7. 5.2.3 Global Oral Vaccination Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oral Vaccination Revenue by Application
  9. 5.3.1 Global Oral Vaccination Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Vaccination Revenue by Application (2021-2032)
  11. 5.3.3 Global Oral Vaccination Revenue Market Share by Application (2021-2032)
6 Global Oral Vaccination Sales by Region
  1. 6.1 Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Vaccination Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Vaccination Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Vaccination Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Vaccination Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Vaccination Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Vaccination Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Vaccination Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Vaccination Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Vaccination Revenue by Region
  1. 7.1 Global Oral Vaccination Revenue by Region
  2. 7.1.1 Global Oral Vaccination Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Vaccination Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Vaccination Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Vaccination Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Vaccination Revenue (2021-2032)
  8. 7.2.2 North America Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Vaccination Revenue (2021-2032)
  11. 7.3.2 Europe Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Vaccination Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Vaccination Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Vaccination Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanzhou Institute
  2. 8.1.1 Lanzhou Institute Company Information
  3. 8.1.2 Lanzhou Institute Business Overview
  4. 8.1.3 Lanzhou Institute Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lanzhou Institute Oral Vaccination Product Portfolio
  6. 8.1.5 Lanzhou Institute Recent Developments
  7. 8.2 Tiantan Biological
  8. 8.2.1 Tiantan Biological Company Information
  9. 8.2.2 Tiantan Biological Business Overview
  10. 8.2.3 Tiantan Biological Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tiantan Biological Oral Vaccination Product Portfolio
  12. 8.2.5 Tiantan Biological Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oral Vaccination Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Oral Vaccination Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Shanghai United Cell
  26. 8.5.1 Shanghai United Cell Company Information
  27. 8.5.2 Shanghai United Cell Business Overview
  28. 8.5.3 Shanghai United Cell Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai United Cell Oral Vaccination Product Portfolio
  30. 8.5.5 Shanghai United Cell Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Oral Vaccination Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Valneva
  38. 8.7.1 Valneva Company Information
  39. 8.7.2 Valneva Business Overview
  40. 8.7.3 Valneva Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Valneva Oral Vaccination Product Portfolio
  42. 8.7.5 Valneva Recent Developments
  43. 8.8 Vabiotech
  44. 8.8.1 Vabiotech Company Information
  45. 8.8.2 Vabiotech Business Overview
  46. 8.8.3 Vabiotech Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vabiotech Oral Vaccination Product Portfolio
  48. 8.8.5 Vabiotech Recent Developments
  49. 8.9 Serum Institute
  50. 8.9.1 Serum Institute Company Information
  51. 8.9.2 Serum Institute Business Overview
  52. 8.9.3 Serum Institute Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute Oral Vaccination Product Portfolio
  54. 8.9.5 Serum Institute Recent Developments
  55. 8.10 Panacea Biotec Ltd
  56. 8.10.1 Panacea Biotec Ltd Company Information
  57. 8.10.2 Panacea Biotec Ltd Business Overview
  58. 8.10.3 Panacea Biotec Ltd Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Panacea Biotec Ltd Oral Vaccination Product Portfolio
  60. 8.10.5 Panacea Biotec Ltd Recent Developments
  61. 8.11 Halfkin Bio-Pharmaceuticals
  62. 8.11.1 Halfkin Bio-Pharmaceuticals Company Information
  63. 8.11.2 Halfkin Bio-Pharmaceuticals Business Overview
  64. 8.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio
  66. 8.11.5 Halfkin Bio-Pharmaceuticals Recent Developments
  67. 8.12 EuBiologics
  68. 8.12.1 EuBiologics Company Information
  69. 8.12.2 EuBiologics Business Overview
  70. 8.12.3 EuBiologics Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EuBiologics Oral Vaccination Product Portfolio
  72. 8.12.5 EuBiologics Recent Developments
  73. 8.13 Emergent BioSolutions
  74. 8.13.1 Emergent BioSolutions Company Information
  75. 8.13.2 Emergent BioSolutions Business Overview
  76. 8.13.3 Emergent BioSolutions Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Emergent BioSolutions Oral Vaccination Product Portfolio
  78. 8.13.5 Emergent BioSolutions Recent Developments
  79. 8.14 Bio-Med
  80. 8.14.1 Bio-Med Company Information
  81. 8.14.2 Bio-Med Business Overview
  82. 8.14.3 Bio-Med Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Med Oral Vaccination Product Portfolio
  84. 8.14.5 Bio-Med Recent Developments
  85. 8.15 Bibcol
  86. 8.15.1 Bibcol Company Information
  87. 8.15.2 Bibcol Business Overview
  88. 8.15.3 Bibcol Oral Vaccination Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bibcol Oral Vaccination Product Portfolio
  90. 8.15.5 Bibcol Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Vaccination Value Chain Analysis
  2. 9.1.1 Oral Vaccination Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Vaccination Production Mode & Process
  6. 9.2 Oral Vaccination Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Vaccination Distributors
  9. 9.2.3 Oral Vaccination Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst